PCA
GILD icon

Providence Capital Advisors’s Gilead Sciences GILD Stock Holding History

Providence Capital Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$37.4K Buy
+296
New +$39K 0.01% 211
2024
Q4 		– Sell
-430
Closed -$36.1K – 195
2024
Q3 		$36.1K Buy
430
+1
+0.2% +$76 0.01% 188
2024
Q2 		$29.5K Buy
429
+1
+0.2% +$67 0.01% 186
2024
Q1 		$31.4K Buy
428
+1
+0.2% +$77 0.01% 182
2023
Q4 		$34.6K Buy
427
+1
+0.2% +$78 0.01% 184
2023
Q3 		$31.9K Buy
426
+2
+0.5% +$154 0.01% 179
2023
Q2 		$32.8K Buy
424
+215
+103% +$17.1K 0.01% 169
2023
Q1 		$17.4K Hold
209
– – ﹤0.01% 190
2022
Q4 		$17.9K Buy
209
+1
+0.5% +$79 ﹤0.01% 178
2022
Q3 		$13K Sell
208
-9
-4% -$568 ﹤0.01% 204
2022
Q2 		$13K Buy
217
+102
+89% +$6.32K ﹤0.01% 197
2022
Q1 		$7K Buy
115
+1
+0.9% +$64 ﹤0.01% 254
2021
Q4 		$8K Sell
114
-1
-0.9% -$69 ﹤0.01% 237
2021
Q3 		$8K Sell
115
-63,199
-100% -$4.44M ﹤0.01% 231
2021
Q2 		$4.36M Buy
63,314
+2,591
+4% +$173K 1.41% 25
2021
Q1 		$3.92M Buy
60,723
+2,121
+4% +$137K 1.43% 28
2020
Q4 		$3.41M Buy
58,602
+11,700
+25% +$706K 1.4% 35
2020
Q3 		$2.96M Buy
46,902
+9,700
+26% +$673K 1.56% 26
2020
Q2 		$2.86M Sell
37,202
-9,398
-20% -$720K 1.62% 25
2020
Q1 		$3.48M Buy
46,600
+1,900
+4% +$131K 2.1% 10
2019
Q4 		$2.9M Buy
+44,700
New +$2.91M 1.56% 22
2019
Q3 		– Sell
-6
Closed – – 235
2019
Q2 		$0 Buy
+6
New +$395 ﹤0.01% 266
2018
Q4 		– Sell
-40
Closed -$3K – 257
2018
Q3 		$3K Hold
40
– – ﹤0.01% 243
2018
Q2 		$3K Sell
40
-73
-65% -$5.16K ﹤0.01% 239
2018
Q1 		$9K Hold
113
– – 0.01% 184
2017
Q4 		$8K Buy
+113
New +$8.58K 0.01% 216

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Providence Capital Advisors's GILD Position: Q2 2026 in Review

Providence Capital Advisors opened a new position in Gilead Sciences (GILD) in Q2 2026: 296 shares worth $37.4K. The stake represents 0.01% of the portfolio and ranks #211 among its holdings. This is a return to the name: Providence Capital Advisors previously reported a position in GILD as recently as Q3 2024.

Providence Capital Advisors first reported a position in GILD in Q4 2017 and has held it in 26 quarters since. The position peaked at $4.36M in Q2 2021. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Providence Capital Advisors held 296 shares of Gilead Sciences worth $37.4K as of Q2 2026.
  • Gilead Sciences was a new Providence Capital Advisors position in Q2 2026.
  • Gilead Sciences made up 0.01% of Providence Capital Advisors's portfolio in Q2 2026, its #211 holding.
  • Providence Capital Advisors first reported a position in Gilead Sciences in Q4 2017 and has held it in 26 quarters since.
  • Providence Capital Advisors's Gilead Sciences position peaked at $4.36M in Q2 2021.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Providence Capital Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.